Market Research Logo

Global Pain Management Drugs Market 2016-2020

About Pain

Pain is defined as a complex medical problem that can have profound effects not only on one's physical but also mental well-being. Pain management is a branch of medicine, which employs approach for easing the suffering and improving the quality of life of individuals suffering from pain. It can be simple or complex type, depending on the cause of pain. Pain management comprises of a variety of skills and techniques used for the treatment of pain.

Technavio’s analysts forecast the global pain management drugs market to grow at a CAGR of 4.97% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global pain management drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs that are used for the management of pain.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Pain Management Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • AstraZeneca
  • Endo International
  • Johnson & Johnson
  • Pfizer
  • Purdue Pharma
Other prominent vendors
  • Allergan
  • AstraZeneca
  • Baxter
  • Bayer
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Durect
  • GlaxoSmithKline
  • Hospira
  • Merck
  • Novartis
  • Pain Therapeutics
  • F. Hoffmann-La Roche
  • Sanofi
  • UCB
  • Valeant
  • Taro Pharmaceuticals
  • Achelios Therapeutics
  • Alder Biopharmace-uticals
  • Amgen
  • CoLucid
  • Daiichi Sankyo
  • Dr. Reddy's Laboratories
  • Eli Lilly
  • GW Pharmaceuticals
  • Immune Pharmaceuticals
  • Innovative Med Concepts
  • NeurAxon
  • OptiNose
  • RedHill
  • Sorrento Therapeutics
  • SUDA
  • Teva
  • Tonix
  • Trigemina
  • WEX Pharmaceuticals
  • Zynerba Pharmaceuticals
Market driver
  • Increase in awareness of pain management drugs
  • For a full, detailed list, view our report
Market challenge
  • Preference for alternative therapies
  • For a full, detailed list, view our report
Market trend
  • Off-label drug usage
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Pain Management Drugs Market 2016-2020

Technavio recognizes the following companies as the key players in the global pain management drugs market: AstraZeneca, Endo International, Johnson & Johnson, Pfizer, and Purdue Pharma.

Other Prominent Vendors in the market are: Allergan, AstraZeneca, Baxter, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Durect, GlaxoSmithKline, Hospira, Merck, Novartis, Pain Therapeutics, F. Hoffmann-La Roche, Sanofi, UCB, Valeant, Taro Pharmaceuticals, Achelios Therapeutics, Alder Biopharmace-uticals, Amgen, CoLucid, Daiichi Sankyo, Dr. Reddy's Laboratories, Eli Lilly, GW Pharmaceuticals, Immune Pharmaceuticals, Innovative Med Concepts, NeurAxon, OptiNose, RedHill, Sorrento Therapeutics, SUDA, Teva, Tonix, Trigemina, WEX Pharmaceuticals, and Zynerba Pharmaceuticals.

Commenting on the report, an analyst from Technavio’s team said: “Increase in research & development activities will be a key trend for market growth. R&D activities for pain drugs are flourishing due to the increasing demand for efficacious and better-tolerated medications. Morphine is one such drug that works through the body's natural pain-killing mechanism, preventing pain messages from reaching the brain. However, adverse responses to morphine are prompting scientists to formulate morphine-like drug, which will have the pain-killing qualities of morphine without its side effects such as sedation and potential addiction.”

According to the report, one of the key drivers for market growth will be rise in older population. The ameliorated standards of healthcare facilities and the availability of sophisticated treatment options are improving life expectancy rates worldwide, leading to a growth in older population. The UN Population Division has projected that the number of people aged 60 years and above will increase exponentially in the near future. In developed countries, the total proportion of people aged 60 years and above has increased from 12% in 1950 to 22% in 2011, and it is expected to reach 32% by 2050.

Further, the report states that preference for alternative therapies will be a challenge for the market. Some pain drugs fail to show the required efficacy in the patients. This forces patients to opt for non-pharmacologic treatments to get relief from the symptoms of the condition. Also, in certain cases, patients become allergic or face side effects from drugs or report deterioration of pre-existing disease with the use of these medications. The non-pharmacologic treatments include lifestyle management with therapies such as acupuncture, massage, and stress management/relaxation techniques including yoga, breathing exercises, tai chi, meditation, biofeedback, hypnotherapy, and cognitive behavioral therapy. These treatments are mainly used as preventive or complementary treatments.



Companies Mentioned

AstraZeneca, Endo International, Johnson & Johnson, Pfizer, Purdue Pharma, Allergan, AstraZeneca, Baxter, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Durect, GlaxoSmithKline, Hospira, Merck, Novartis, Pain Therapeutics, F. Hoffmann-La Roche, Sanofi, UCB, Valeant, Taro Pharmaceuticals, Achelios Therapeutics, Alder Biopharmace-uticals, Amgen, CoLucid, Daiichi Sankyo, Dr. Reddy's Laboratories, Eli Lilly, GW Pharmaceuticals, Immune Pharmaceuticals, Innovative Med Concepts, NeurAxon, OptiNose, RedHill, Sorrento Therapeutics, SUDA, Teva, Tonix, Trigemina, WEX Pharmaceuticals, Zynerba Pharmaceuticals.

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
    • Top-vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
    • Assessment of pain
      • Table Pain assessment
      • Table Types of pain scales
    • Treatment
      • Table Treatment options for pain
      • Table Commonly used non-opioids for pain management
      • Table Commonly used adjuvant medicines for pain
      • Table Pain management
  • Pipeline portfolio
    • Table Pipeline portfolio: Major drug candidates under development for pain management
    • Information on pipeline candidates
  • Market landscape
    • Market overview
    • Market size and forecast
      • Table Global pain management drugs market 2015-2020 ($ billions)
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by drug class
    • Table Global pain management drugs market by drug class
    • Opioids
    • NSAIDs
    • Other
      • Table Segmentation of global pain management drugs market by drug class, 2015
    • Global opioids market
      • Table Global opioids market 2015-2020 ($ billions)
      • Table Key drivers and challenges of global opioids market
    • Global NSAIDs market
      • Table Global NSAIDs market 2015-2020 ($ billions)
      • Table Key drivers and challenges of global NSAIDs market
  • Market segmentation by type
    • Table Global pain management drugs market segmentation by type
    • Musculoskeletal pain
    • Surgical and trauma pain
    • Cancer pain
    • Neuropathic pain
    • Migraine pain
    • Obstetrical pain
    • Fibromyalgia pain
    • Burn pain
    • Dental/facial pain
    • Pediatric pain
      • Table Global pain management drugs market segmentation 2015
    • Global musculoskeletal pain drugs market
      • Table Global musculoskeletal pain drugs market 2015-2020 ($ billions)
    • Global surgical and trauma pain drugs market
      • Table Global surgical and trauma drugs market 2015-2020 ($ billions)
    • Global cancer pain drugs market
      • Table Global cancer pain drugs market 2015-2020 ($ billions)
    • Global neuropathic pain drugs market
      • Table Global neuropathic pain drugs market 2015-2020 ($ billions)
    • Global migraine pain drugs market
      • Table Global migraine pain drugs market 2015-2020 ($ billions)
    • Global obstetrical pain drugs market
      • Table Global obstetrical pain drugs market 2015-2020 ($ billions)
    • Global fibromyalgia pain drugs market
      • Table Global fibromyalgia pain drugs market 2015-2020 ($ billions)
    • Global burn pain drugs market
      • Table Global burn pain drugs market 2015-2020 ($ billions)
    • Global dental/facial pain drugs market
      • Table Global dental/facial pain drugs market 2015-2020 ($ billions)
    • Global pediatric pain drugs market
      • Table Global pediatric pain drugs market 2015-2020 ($ billions)
      • Table Global pain management drugs market by type: YoY revenue and growth 2015-2020
  • Geographical segmentation
    • Table Global pain management drugs market by geographical segmentation 2015
    • Table Global pain management drugs market revenue by geography 2015-2020 ($ billions)
    • Pain management drugs market in Americas
      • Table Pain management drugs market in Americas 2015-2020 ($ billions)
    • Pain management drugs market in EMEA
      • Table Pain management drugs market in EMEA 2015-2020 ($ billions)
    • Pain management drugs market in APAC
      • Table Pain management drugs market in APAC 2015-2020 ($ billions)
      • Table Global pain management drugs market: YoY revenue and growth based on geography 2015-2020
  • Market drivers
    • Rise in older population
    • Promising pipeline
    • Increase in awareness of pain management drugs
    • Favorable regulatory scenario
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • Table Challenges in global pain management drugs market
    • Generic competition
    • Adverse effects
    • Preference for alternative therapies
    • Short-term relief
    • Threat of counterfeit products
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Table Trends in global pain management drugs market
    • Increase in R&D activities
    • Off-label drug usage
    • Strategic alliances
  • Vendor landscape
    • Competitive scenario
    • AstraZeneca
      • Table AstraZeneca: Key pain products segmentation by revenue 2014
      • Table AstraZeneca: YoY growth rate and revenue of Vimovo 2012-2014 ($ millions)
      • Table AstraZeneca: Key takeaways
    • Endo International
      • Table Endo International: YoY growth rate and revenue of Opana ER 2012-2014 ($ millions)
      • Table Endo International: YoY growth rate and revenue of Voltaren 2012-2014 ($ millions)
      • Table Endo International: YoY growth rate and revenue of Lidoderm 2012-2014 ($ millions)
      • Table Endo International: YoY growth rate and revenue of Percocet 2012-2014 ($ millions)
      • Table Endo International: Key takeaways
    • Johnson & Johnson
      • Table Johnson & Johnson: Key takeaways
    • Pfizer
      • Table Pfizer: YoY growth rate and revenue of Lyrica 2012-2014 ($ billions)
      • Table Pfizer: YoY growth rate and revenue of Celebrex 2012-2014 ($ billions)
      • Table YoY growth rate and revenue of Relpax 2012-2014 ($ millions)
      • Table Pfizer: Key takeaways
    • Purdue Pharma
      • Table Purdue Pharma: Key takeaways
    • Other prominent vendors
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report